Millennium Management
ACHV icon

Millennium Management’s Achieve Life Sciences ACHV Stock Holding History

Millennium Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-136
Closed -$1.12M – 3647
2014
Q2 		$1.12M Hold
136
– – ﹤0.01% 2139
2014
Q1 		$3.53M Buy
+136
New +$3.34M 0.01% 1408

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management's ACHV Position: Q1 2026 in Review

Millennium Management reduced its Achieve Life Sciences (ACHV) stake by 21% in Q1 2026, selling an estimated $1.25M and leaving 1,077,338 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Millennium Management first reported a position in ACHV in Q4 2013 and has held it in 20 quarters since. The position peaked at $6.75M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Millennium Management held 1,077,338 shares of Achieve Life Sciences worth $3.17M as of Q1 2026.
  • Millennium Management sold 281,778 Achieve Life Sciences shares in Q1 2026, an estimated $1.25M.
  • Achieve Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3423 holding.
  • Millennium Management first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 20 quarters since.
  • Millennium Management's Achieve Life Sciences position peaked at $6.75M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.